Поиск

We are pleased to announce that our clinic is again welcoming allergist-immunologist Botirov Azizbek Mazoidovich! Dr. Botirov specializes in the diagnosis and treatment of allergic and immunodeficiency conditions. In his competence: Diagnostics and ...

Amivantamab plus Lasertinib versus Osimertinib for first-line treatment of EGFR-mutated advanced NSCLC. Activating mutations in the EGFR gene occur in 15–50% of cases of non-squamous non-small cell lung cancer (NSCLC). These are usually deletions of exon ...

Amivantamab plus Lasertinib versus Osimertinib for first-line treatment of EGFR-mutated advanced NSCLC. Activating mutations in the EGFR gene occur in 15–50% of cases of non-squamous non-small cell lung cancer (NSCLC). These are usually deletions of exon ...

Long-term results of adjuvant therapy with dabrafenib and trametinib in stage III melanoma. COMBI-AD study. This study presents the final analysis of a phase III trial that evaluated the use of 12 months of adjuvant dabrafenib plus trametinib. in patients ...

Long-term results of adjuvant therapy with dabrafenib and trametinib in stage III melanoma. COMBI-AD study. This study presents the final analysis of a phase III trial that evaluated the use of 12 months of adjuvant dabrafenib plus trametinib. in patients ...

The clinic was presented by Anastasia Vladimirovna Varvyanskaya, otolaryngologist K+31 West. She moderated and spoke at a meeting on olfactory dysfunction, and also co-authored the first practical recommendations in Russia for doctors on the diagnosis and ...

The clinic was presented by Anastasia Vladimirovna Varvyanskaya, otolaryngologist K+31 West. She moderated and spoke at a meeting on olfactory dysfunction, and also co-authored the first practical recommendations in Russia for doctors on the diagnosis and ...